C. Roemer-Bécuwe

719 total citations
15 papers, 346 citations indexed

About

C. Roemer-Bécuwe is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, C. Roemer-Bécuwe has authored 15 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Obstetrics and Gynecology and 5 papers in Reproductive Medicine. Recurrent topics in C. Roemer-Bécuwe's work include Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). C. Roemer-Bécuwe is often cited by papers focused on Endometrial and Cervical Cancer Treatments (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Colorectal Cancer Treatments and Studies (3 papers). C. Roemer-Bécuwe collaborates with scholars based in France, Italy and Canada. C. Roemer-Bécuwe's co-authors include Christine M. Cheng, José Pereira, Éric Pujade-Lauraine, D. Paraïso, B. Weber, Florence Joly, Anne Floquet, Philippe Bougnoux, Michel Fabbro and Isabelle Ray‐Coquard and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C. Roemer-Bécuwe

15 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Roemer-Bécuwe France 8 152 105 88 73 63 15 346
Kristen Starbuck United States 10 84 0.6× 56 0.5× 51 0.6× 51 0.7× 49 0.8× 29 314
Ingolf Juhasz-Böess Germany 12 96 0.6× 87 0.8× 131 1.5× 105 1.4× 27 0.4× 28 397
Tina Rizack United States 9 127 0.8× 42 0.4× 32 0.4× 45 0.6× 33 0.5× 20 336
Caitlin Carr United States 10 140 0.9× 64 0.6× 92 1.0× 53 0.7× 29 0.5× 29 454
Chuenkamon Charakorn Thailand 11 77 0.5× 46 0.4× 161 1.8× 130 1.8× 46 0.7× 19 374
D.Y.S. Kuo United States 10 66 0.4× 34 0.3× 120 1.4× 87 1.2× 43 0.7× 20 321
Luis Sanfrutos Spain 11 72 0.5× 73 0.7× 307 3.5× 159 2.2× 47 0.7× 21 562
Shiho Kuji Japan 10 185 1.2× 95 0.9× 113 1.3× 92 1.3× 23 0.4× 24 431
Gail T. McDonald Canada 8 40 0.3× 51 0.5× 99 1.1× 21 0.3× 43 0.7× 17 317
Zeyang Chen China 11 51 0.3× 128 1.2× 20 0.2× 17 0.2× 66 1.0× 36 369

Countries citing papers authored by C. Roemer-Bécuwe

Since Specialization
Citations

This map shows the geographic impact of C. Roemer-Bécuwe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Roemer-Bécuwe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Roemer-Bécuwe more than expected).

Fields of papers citing papers by C. Roemer-Bécuwe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Roemer-Bécuwe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Roemer-Bécuwe. The network helps show where C. Roemer-Bécuwe may publish in the future.

Co-authorship network of co-authors of C. Roemer-Bécuwe

This figure shows the co-authorship network connecting the top 25 collaborators of C. Roemer-Bécuwe. A scholar is included among the top collaborators of C. Roemer-Bécuwe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Roemer-Bécuwe. C. Roemer-Bécuwe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Selle, Frédèric, Pierre-Étienne Heudel, Youssef Tazi, et al.. (2017). Outcomes of the combination trabectedin and pegylated liposomal doxorubicin (T-PLD) in recurrent platinum-sensitive ovarian cancer (OC): a GINECO cohort study. Annals of Oncology. 28. v344–v345. 1 indexed citations
3.
Boisdron‐Celle, M., Olivier Capitain, Roger Faroux, et al.. (2017). Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach. Seminars in Oncology. 44(1). 13–23. 57 indexed citations
4.
5.
Curigliano, Giuseppe, Gilles Romieu, Mario Campone, et al.. (2016). A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment. 156(2). 301–310. 41 indexed citations
6.
7.
Heudel, Pierre-Étienne, Michel Fabbro, C. Roemer-Bécuwe, et al.. (2015). Phase II study of the PI3K inhibitor BKM120 monotherapy in patients with advanced or recurrent endometrial carcinoma: ENDOPIK, GINECO Study.. Journal of Clinical Oncology. 33(15_suppl). 5588–5588. 6 indexed citations
8.
Ray‐Coquard, Isabelle, Laure Favier, B. Weber, et al.. (2013). Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. British Journal of Cancer. 108(9). 1771–1777. 73 indexed citations
9.
Boisdron‐Celle, M., Olivier Capitain, Jean‐Philippe Metges, et al.. (2013). Prevention of 5-FU-induced health-threatening toxicity by pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.. Journal of Clinical Oncology. 31(15_suppl). 3601–3601. 6 indexed citations
10.
Boisdron‐Celle, M., Olivier Capitain, Roger Faroux, et al.. (2013). Prevention of 5-FU-induced toxicities using pretherapeutic DPD deficiency screening: Medical and economic assessment of a multiparametric approach.. Journal of Clinical Oncology. 31(4_suppl). 351–351. 2 indexed citations
11.
Kurtz, J.E., Anne‐Claire Hardy‐Bessard, Marion Deslandres, et al.. (2009). Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial. Gynecologic Oncology. 113(1). 16–20. 62 indexed citations
12.
Kurtz, Ellen S., Dominique Besson, Marion Deslandres, et al.. (2008). Cetuximab (Ce) + topotecan (Tc) + cisplatin (Cp) for the treatment (Tt) of advanced cervix cancer (ACC): A phase II GINECO trial. Journal of Clinical Oncology. 26(15_suppl). 5512–5512. 2 indexed citations
13.
Roemer-Bécuwe, C., Antonio Viganò, Fabrizio Romano, et al.. (2003). Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. Journal of Pain and Symptom Management. 26(3). 843–848. 14 indexed citations
14.
Roemer-Bécuwe, C., I. Krakowski, & Thierry Conroy. (2003). [Bisphosphonates, pain and quality of life in metastatic breast cancer patients: a literature review].. PubMed. 90(12). 1097–105. 8 indexed citations
15.
Cheng, Christine M., C. Roemer-Bécuwe, & José Pereira. (2002). When Midazolam Fails. Journal of Pain and Symptom Management. 23(3). 256–265. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen Starbuck Breakdown of academic impact, for papers by Ingolf Juhasz-Böess Breakdown of academic impact, for papers by Tina Rizack Breakdown of academic impact, for papers by Caitlin Carr Breakdown of academic impact, for papers by Chuenkamon Charakorn Breakdown of academic impact, for papers by D.Y.S. Kuo Breakdown of academic impact, for papers by Luis Sanfrutos Breakdown of academic impact, for papers by Shiho Kuji Breakdown of academic impact, for papers by Gail T. McDonald Breakdown of academic impact, for papers by Zeyang Chen
Rankless by CCL
2026